Silk Road Medical, Inc (SILK)
| Market Cap | 477.86M |
| Revenue (ttm) | 169.94M |
| Net Income (ttm) | -55.44M |
| Shares Out | 38.95M |
| EPS (ttm) | -1.44 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 514,583 |
| Open | 12.45 |
| Previous Close | 12.44 |
| Day's Range | 12.10 - 12.53 |
| 52-Week Range | 6.08 - 58.04 |
| Beta | 1.38 |
| Analysts | Hold |
| Price Target | 23.25 (+89.49%) |
| Earnings Date | Feb 27, 2024 |
About SILK
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid a... [Read more]
Financial Performance
In 2022, SILK's revenue was $138.64 million, an increase of 36.62% compared to the previous year's $101.48 million. Losses were -$55.18 million, 10.7% more than in 2021.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for SILK stock is "Hold." The 12-month stock price forecast is $23.25, which is an increase of 89.49% from the latest price.
News
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SUNNYVALE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wi...
Silk Road Medical Reports Third Quarter 2023 Financial Results
SUNNYVALE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial resul...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK
NEW YORK , Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such investors are advise...
Silk Road Medical to Report Third Quarter 2023 Financial Results on November 8, 2023
SUNNYVALE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report...
Silk Road Medical Stock Sinks. Here's Why Citi Says Sell.
Two pieces of news are weighing on shares of the medical devices company.
Novo Nordisk shares rise, Silk Road Medical stock slumps and other movers
Shares of Thor Industries Inc. THO rose 2% after the RV maker said its board authorized a 7% dividend increase to 48 cents a share.
Silk Road Medical stock falls following outlook, CEO's retirement
Silk Road Medical Inc. SILK, -0.71% shares dropped in the extended session Tuesday after the medical device company updated its forecast and said its chief executive was retiring. The company forecast...
Silk Road Medical Announces Preliminary Third Quarter 2023 Revenue and Provides Revised 2023 Outlook
SUNNYVALE, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced preliminary re...
Silk Road Medical Announces Retirement of CEO Erica Rogers
Working with Leading Executive Search Firm to Identify Successor SUNNYVALE, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of ...
Silk Road Medical to Present at the CL King 21st Annual Best Ideas Conference
SUNNYVALE, Calif., Sept. 04, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that manageme...
Silk Road Medical to Present at the UBS MedTech, Tools and Genomics Summit
SUNNYVALE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wi...
Silk Road Medical Reports Second Quarter 2023 Financial Results
SUNNYVALE, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial resul...
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This MonthSilk Road Me
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Silk Road Medical stock tanks after CMS decision on carotid artery stenting prompts analyst downgrade
Shares of Silk Road Medical Inc. SILK, -20.18% tanked 21.9% toward a more-than three-year low in premarket Tuesday, after an unfavorable government decision regarding Medicare coverage of carotid arte...
Silk Road Medical to Report Second Quarter 2023 Financial Results on August 1, 2023
SUNNYVALE, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report...
Silk Road Medical Receives 2023 Great Place To Work Certification™
SUNNYVALE, Calif., May 05, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has bee...
Silk Road Medical Announces Investor Education Webcast with Key Opinion Leaders
SUNNYVALE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that the compan...
Silk Road Medical to Present at the BofA Securities 2023 Healthcare Conference
SUNNYVALE, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company w...
Silk Road Medical to Report First Quarter 2023 Financial Results on May 9, 2023
SUNNYVALE, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will repor...
Silk Road Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Outlook
SUNNYVALE, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial resul...
Silk Road Medical to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
SUNNYVALE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report...
Silk Road Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
SUNNYVALE, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wi...
Silk Road Medical to Present at Upcoming Investor Conferences
SUNNYVALE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that manageme...
Silk Road Medical to Report Third Quarter 2022 Financial Results on November 8, 2022
SUNNYVALE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report...
Silk Road Medical Announces Pricing of Public Offering
SUNNYVALE, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the pricing of...